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LMP1 induces the expression of two members of the family of Id proteins, Id1 and Id3, and affects cell cycle regulation by decreasing the
expression of the cyclin dependent kinase inhibitor, p27, and increasing levels and phosphorylation of cdk2 and Rb. In the present study, the
contribution of the Id proteins to LMP1-mediated transformation was determined. Although LMP1 effectively inhibited p27 expression, the Id
proteins alone did not affect expression of p27, cdk2, and Rb. Neither Id1 nor Id3 was sufficient to transform Rat-1 cells and inhibition of Id1
expression did not affect LMP1-induced morphologic transformation of Rat-1 cells or reduction of p27. However, reduced Id expression resulted
in smaller foci and impaired the growth rate of Rat-1 cells. These data indicate that overexpression of the Id proteins is not sufficient for the effects
of LMP1 on the cell cycle but that inhibition of Id expression does affect the growth of LMP1-transformed and parental Rat1 cells.
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Epstein–Barr virus (EBV) is a DNA tumor virus that
efficiently transforms B-lymphocytes in vitro and is associated
with a number of epithelial and lymphoid malignancies (Kieff,
2007; Raab-Traub, 2002; Young et al., 1989; Young and
Rickinson, 2004). Latently infected B-cells initially express a
number of EBV proteins and factors important to ensure the
survival of the latently infected cell. The latently infected cells
express different subsets of latent proteins and these gene
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doi:10.1016/j.virol.2007.12.003ciated disease states. In nasopharyngeal carcinoma (NPC) and
some types of Hodgkin disease, latent membrane protein 1
(LMP1), latent membrane protein 2 (LMP2A, LMP2B), EBV
nuclear antigen 1 (EBNA1), and the EBER and BamHI-A
transcripts are expressed (Kieff, 2007).
Many of the EBV proteins expressed during latency have
profound effects on gene regulation, control cell growth, and
several key pathways that are affected have been identified. The
nuclear proteins, EBNA2, EBNA3A, B, and C impinge on
Notch signaling (Grossman et al., 1994; Henkel et al., 1994;
Robertson et al., 1996a,b) and LMP2A inhibits B-cell receptor
signaling (Miller et al., 1995, 1994, 1993) and activates
phosphatidylinositol 3-kinase (PI3K) (Morrison et al., 2003;
Scholle et al., 2000; Swart et al., 2000). LMP1 is a constitutively
active member of the tumor necrosis factor receptor family and
activates NFκB, PI3K, mitogen-activated protein kinases
(MAPK), and c-Jun N-terminal kinase (JNK) signaling (Dawson
et al., 2000; Eliopoulos andYoung, 1998; Izumi andKieff, 1997;
Mainou et al., 2005; Miller et al., 1997; Paine et al., 1995;
Roberts and Cooper, 1998; Thornburg et al., 2006). Recently
viral microRNAs have been identified as being processed from
the BamHI-A transcripts (Cai et al., 2006).
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is considered the EBV oncogene as it can transform rodent
fibroblasts by conferring anchorage-independent growth and
loss of contact inhibition (Baichwal and Sugden, 1988; Everly
et al., 2004; Kaye et al., 1993; Wang et al., 1985). Fibroblasts
expressing LMP1 form tumors in nude mice and can grow in
reduced serum conditions (Wang et al., 1985). The LMP1
protein has a short cytoplasmic amino-terminus and a six-pass
integral membrane domain. The transmembrane domain med-
iates ligand-independent self-association (Devergne et al., 1996;
Franken et al., 1996). Oligomerization in the membrane initiates
signaling from two carboxyl-terminal activating regions
(CTARs), CTAR1 and CTAR2, by recruiting adapter molecules
including tumor necrosis receptor associated factors (TRAFs).
CTAR1 can bind TRAF1, 2, 3, or 5, while CTAR2 recruits
TRAF2 and 6 through binding of other factors like tumor
necrosis factor receptor associated death domain (TRADD)
protein, RIP and BS69 (Devergne et al., 1996; Izumi et al., 1999,
1997; Izumi and Kieff, 1997; Miller et al., 1998; Mosialos et al.,
1995; Wan et al., 2006). Signaling induced by LMP1 is anal-
ogous to constitutively activated tumor necrosis factor receptor
(TNFR) signaling and LMP1 is constitutively present in the
cholesterol-rich lipid raft domains (Ardila-Osorio et al., 2005;
Higuchi et al., 2001; Pioche-Durieu et al., 2005; Yasui et al.,
2004). Experiments using rodent fibroblasts have determined
that LMP1 via CTAR1 induces two members of the family of Id
proteins, Id1 and Id3, and regulates the cell cycle by down-
regulating the expression of cyclin dependent kinase inhibitor,
p27KIP, and increasing levels and phosphorylation of cdk2 and
Rb (Everly et al., 2004).
The Id proteins are a family of proteins named both for their
ability to inhibit DNA binding and inhibit differentiation (Sikder
et al., 2003). There are four members of the family of Id proteins,
Id1, Id2, Id3, and Id4. The Id proteins do not dimerize with each
other but do contain a helix–loop–helix domain that allows them
to heterodimerize and negatively regulate helix–loop–helix
transcription factor family members (E-box proteins). Id pro-
teins lack the basic DNA-binding domains present in the E-box
proteins and are thought to act as dominant-negative transcrip-
tion factors by altering the subnuclear localization of the E-box
proteins, from chromatin-associated to freely diffusing (O'Toole
et al., 2003). They are critical regulators of cell growth as they
inhibit differentiation and promote cell cycle progression
(Barone et al., 1994; Hara et al., 1994; Peverali et al., 1994).
The expression of the Id proteins is deregulated and increased in
many cancers and knockout mouse models containing deletions
of the Id proteins have developmental defects (Perk et al., 2005).
Important targets of the Id proteins are the cyclin dependent
kinase inhibitors (cdki) that are critical regulators of the cell
cycle. Expression of two cdkis is controlled in part by the
repressive and activating activity of the Id and E-box proteins,
respectively (Ohtani et al., 2001; Prabhu et al., 1997; Zheng
et al., 2004). Id1 and several E-box proteins, E47 and Ets1/2,
regulate the p16INK4 promoter (Ohtani et al., 2001; Zheng et al.,
2004). Another E-box protein, E2A, regulates cdki p21WAF1 in
conjunction with Id1 and controls cell growth (Prabhu et al.,
1997).In the present study, the contribution of the Id proteins to
LMP1-mediated effects on the cell cycle proteins and trans-
formation was determined. Although LMP1 effectively inhib-
ited p27 expression, the Id proteins did not affect expression of
p27 or other regulators of the cell cycle. Neither Id1 nor Id3 was
sufficient to transform Rat-1 cells. Silencing Id1 expression did
not block LMP1-mediated transformation, however, the growth
of both control and LMP1 expressing Rat-1 cells was impaired.
The data indicate that the Id proteins contribute to the growth of
LMP1-transformed cells but are not required for the effects of
LMP1 on cell cycle markers.
Results
LMP1 induces the expression of two members of the Id
family of proteins, Id1 and Id3, in epithelial cells and during
rodent fibroblast transformation (Everly et al., 2004). Id pro-
teins have been shown to bind to helix–loop–helix transcription
factor family members, inhibit differentiation, and promote
proliferation (Barone et al., 1994; Hara et al., 1994; Peverali
et al., 1994; Sikder et al., 2003). The overexpression of Id1 in
primary epithelial cells delays senescence and in some cases
leads to their immortalization (Alani et al., 1999; Nickoloff
et al., 2000). In addition, Id proteins are often deregulated and
overexpressed in many cancers (Perk et al., 2005). In this study,
the contribution of the Id proteins to LMP1-mediated rodent
fibroblast transformation was determined.
Id1 and Id3 are insufficient for transformation of Rat-1 cells
To determine if the Id proteins have transforming properties,
Rat-1 cells were transduced with the vector control, pBabe, or
retroviruses expressing LMP1, Id1, or Id3, and selected with
puromycin for stable cell lines. Stable cell lines were plated and
incubated at confluency for 10–14 days and tested for ability to
overcome contact-inhibition of growth (Fig. 1). The pBabe
control cells were contact inhibited and stopped growing once
the monolayer reached confluency. In contrast, the LMP1
expressing cells were transformed, overcame contact-inhibition,
and continued to grow. Neither the cells expressing Id1 nor the
cells expressing Id3 were able to transform Rat-1 cells, as they
were contact inhibited and did not continue to grow once the
cells reached confluency (bottom panels). Expression of LMP1
and expression of myc-tagged Id proteins were confirmed by
western blotting for LMP1 and the myc-epitope tag, respec-
tively (Fig. 2). Detection of the tagged Id constructs was also
confirmed using Id-specific antibodies and indicated that the
levels of expression of the tagged Id proteins were similar to that
induced by LMP1 (data not shown). The cell lines stably
expressing Id1 or Id3 were also transduced with retrovirus
expressing Id3 or Id1, respectively, and analyzed for focus
formation. No foci were detected in either the Id1 stable cells
with Id3 retrovirus or Id3 stable cells with Id1 retrovirus. These
data indicate that the induced expression of the Id proteins is not
sufficient to transform fibroblasts and that other properties of
LMP1, possibly in concert with the induction of the Id proteins,
are required for transformation.
Fig. 1. Rat-1 transformation by LMP1, Id1, and Id3. Rat-1 cells were transduced with the control retrovirus, pBabe, or retrovirus expressing LMP1, or myc-tagged Id1
or Id3, M3-Id1 or M3-Id3, respectively. Stable cell lines were selected with puromycin, plated in 6-well plates, and allowed to grow for 7 to 10 days to assess effects on
contact inhibition. Monolayers were fixed, stained with crystal violet, and photographed by light microscopy using a dissecting microscope. Representative monolayer
fields are presented.
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Although the overexpression of the Id proteins was not
sufficient to transform Rat-1 cells, the effects of the Id proteins
on the cell cycle markers that are affected by LMP1 during
transformation were determined. The Id proteins have been
shown to regulate expression of the cyclin dependent kinase
inhibitors, p16INK and p21WAF. Rat-1 fibroblasts do not
express p16 or p21 and only express the p27 cdki enabling
assessment of the effects of the Id proteins on p27. As
previously shown, expression of the cyclin dependent kinase
inhibitor, p27, was markedly decreased in the LMP1-expressing
cells (Fig. 2). However, in the cell lines stably expressing Id1 or
Id3 expression of p27 were not affected. Cell lines that stably
expressed both Id1 and Id3 also failed to downregulate p27
(data not shown).
The effects of the Id proteins on other aspects of the cell
cycle that are altered during LMP1-mediated transformation
were also determined. In Rat-1 cells transformed with LMP1,
the amount of cyclin dependent kinase 2 (cdk2) and hyperpho-
sphorylated Rb and total Rb was increased as previously
described (Fig. 2). However, in the cells expressing Id1 or Id3,
the amounts of p27, cdk2, and Rb were not affected (Fig. 2).
These findings indicate that the cell cycle proteins that areaffected by LMP1 during transformation are not affected by
overexpression of the Id proteins in the absence of LMP1.
LMP1 regulates p27KIP transcription
Both transcriptional and post-transcriptional regulation of p27
has been described (Auerkari, 2006; Chandramohan et al., 2004).
To determine if LMP1 or the Id proteins affected p27
transcription, Rnase protection assays (RPA) were performed
using extracts from the stable cell lines expressing LMP1 or the Id
proteins. The Id proteins are serum responsive proteins, therefore
RNA was harvested from cells in full serum or after serum-
starving (0.2%) for 16 h. The RNA was annealed with rat p27
probe, digested, and resolved on polyacrylamide gels. Protected
p27 fragments were quantitated using a phosphorimager and
plotted relative to GAPDH RNA levels (Fig. 3, panel A). In the
presence or absence of serum, LMP1 decreased p27 RNA levels
approximately 70–80%, similarly to its effects on the protein
levels (Fig. 2). The Id proteins did not affect p27 RNA levels.
To ensure that the failure to downregulate p27 was not the
result of the triple myc-tag at the N-terminus, the Id proteins
were subcloned with a carboxyl-terminal HA tag or untagged.
Neither the N-terminally myc-tagged nor C-terminally HA-
tagged versions of the Id proteins affected p27 RNA levels
Fig. 3. Regulation of p27KIP transcription. Regulation of the p27KIP promoter
was determined by ribonuclease protection assays (A) and promoter reporter
assays (B). Ribonuclease protection assays (A) were performed using total RNA
from stable cell lines. Fragments protected by rat p27KIP RNA probe relative to
control (GAPDH) RNA probe were quantitated using a Phosphorimager and p27
expression is depicted relative to control (Babe) stables set arbitrarily as one.
Stable cell lines included cells expressing LMP1, untagged Id proteins, Id1 and
Id3, C-terminally HA-tagged Id proteins, Id1-HA and Id3-HA, and N-terminally
triple myc-tagged Id proteins, M3-Id1 and M3-Id3. The experiment was
performed three times and a representative experiment is presented. Promoter
reporter assays (B) were performed by transfection of 293T cells with control
pRL-SV40, pGL3-Basic (empty reporter) or p27-1501 (containing 1500 base
pairs of the Rattus novegicus p27KIP promoter) reporter plasmids, and vector
control (Babe) or plasmids expressing LMP1, or untagged Id1 or Id3. Forty hours
post-transfection cells were harvested, and dual-luciferase assays were
performed. Relative luciferase activity was determined by the firefly luciferase
activity of the reporter constructs relative to the control renilla luciferase activity.
Error bars represent the standard deviation from the mean in triplicate wells.
Fig. 2. Regulation of cell cycle markers in Rat-1 stable cells. Rat-1 cell lines
stably expressing LMP1, Id1, or Id3 were analyzed by western blotting. Total
cell lysates from control (pBabe), LMP1, myc-tagged Id1 (M3-Id1), or myc-
tagged Id3 (M3-Id3) were analyzed for levels of p27, Cdk2 and Rb protein.
Actin was used as a loading control and expression of constructs was confirmed
by blotting with LMP1-specific and myc-tag antibodies. Fifty micrograms of
protein were loaded per lane.
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expressing untagged Id1 and Id3, p27 RNA levels were also
approximately equivalent or slightly higher than the control cell
levels. Expression of the differentially tagged Id proteins in
stable cell lines was confirmed by western blotting. The
expression levels of the tagged Id proteins in the stable lines
were also assessed using antibodies to Id1 and Id3. These assays
revealed that expression of Id1 and Id3 was approximately two
to three times greater than control cell lines and was comparable
to the levels induced by LMP1 ((Everly et al., 2004) and data
not shown).
To assess the ability of LMP1 or the Id proteins to regulate the
p27KIP promoter, the control region (1500 base pairs) of the
p27KIP promoter was cloned into a promoter reporter constructs
for reporter assays. 293Tcells were cotransfected with the empty
reporter vector (pGL3-Basic) or p27 reporter (p27–1501), trans-
fection control renilla luciferase, and effector plasmids, encod-
ing LMP1, Id1 or Id3. p27 promoter activity was plotted relative
to the internal control renilla luciferase activity (Fig. 3B). LMP1
decreased the activity of the p27 promoter reporter plasmid
indicating that LMP1 regulates the p27KIP1 promoter. How-
ever, confirming the western blotting and RPA assays, the Id
proteins did not negatively regulate the p27 promoter reporter.
These findings indicate that LMP1 negatively regulates p27
expression transcriptionally but that the expression of Id1 or Id3,
in the absence of LMP1, is not sufficient for this effect.
To determine if inhibition of Id expression affects the ability
of LMP1 to decrease p27 expression, siRNA for a negative
control siRNA (Cy3), Id1, Id3, or for both Id1 and Id3 was
transfected into Rat1 cells which were then transduced with
LMP1. Expression of Id1 was assessed using an Id1 specific
antibody (Fig. 4A). The levels of expression were normalized toactin and quantitated (Fig. 4B). The Id1 siRNA reduced Id1
expression approximately 60%. The effect of the Id3 siRNA
could not be determined due to the poor quality of the Id3
antibody. As shown, in some experiments, the Id3 siRNA
increased expression of Id1, however, this unexpected effect did
indicate successful transfection of the Id3 siRNA. When both
Id1 and Id3 siRNAs were transfected, the level of Id1 was again
reduced by 60%. Despite successful transfection of the siRNAs
and effective reduction of Id1 expression, the levels of p27 did
not increase as anticipated but rather were further decreased
(Fig. 4B). These data suggest that the LMP1-induced decrease
of p27 is not mediated by its ability to increase Id1 and Id3.
Inhibition of Id1 expression in Rat-1 cells
To assess the possible contribution of Id expression to LMP1-
mediated transformation, expression of Id1 was inhibited with
Fig. 4. Effects of siId1 and siId3 on LMP1-mediated decrease of p27. Rat-1 cells
were transfected with negative control siRNA (Cy3), siId1, siId3, or siId1 and
siId3 and transduced with LMP1-expressing retrovirus, HSCG-LMP1. Expres-
sion of Id1 and p27 was determined by immunoblotting (panel A). Expression of
Id1 and p27 was quantitated relative to actin expression (numbers below Id1 blot
in panel A and black and white bars, respectively, in panel B) using ImageJ
densitometry software.
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were transiently transfected with Cy3-labeled negative control
or Id1 siRNA and then transduced with GFP-expressing
retroviruses, pHSCG (control) or pHSCG-LMP1. The trans-
fected and transduced cells were then allowed to grow for 7 days
to assess transformation. Monolayers were examined at the end
of the experiment by phase contrast and fluorescence micro-
scopy to analyze transfection and transduction. Efficiency of
siRNA transfection was assessed by fluorescence of the cells
transfected with the Cy3-labelled control siRNA. Greater than
95% of the cells were transfected indicating efficient transfection
of siRNAs (data not shown). Co-expression of green fluorescent
protein was used as a control for retrovirus transduction ef-
ficiency and differences were not detected in the numbers of
green cells between control and LMP1 expressing retrovirus in
the presence or absence of Id1 siRNA. Monolayers were stained
with crystal violet and examined for focus formation (Fig. 5). In
the presence of the nonspecific siRNA, LMP1 transformed Rat-1
cells and formed foci (Fig. 5B and F). However in the presence
of Id1 siRNA, the foci were fewer and smaller (Fig. 5D and H).
As shown in Fig. 4, Id1 was effectively targeted by the silencing
sequence.
Fluorescence microscopy (Fig. 6) revealed that in the cells
transfected with control siRNA, LMP1 induced brightly green
and transformed foci (Fig. 6A and D, respectively). In the cellstransfected with siRNA to Id1, patches of green LMP1
transduced cells were detected. The cells were not as large as
the control LMP1 expressing cells but appeared morphologi-
cally different than the surrounding cells (Fig. 6B and E,
respectively). At high power the siId1 transfected cells that were
transduced with LMP1 (green) were rounded and refractile,
suggestive of transformation (Fig. 6C and F, respectively). The
cells adjacent to the foci were normal and control cells
expressing only GFP had normal morphology identical to
surrounding untransduced cells. These observations indicate
that the siId1 RNAwas not toxic. The smaller foci observed in
the Id1 siRNA transfected cells could be due to decreased
silencing after 7 days, which is considered to be the limit of the
efficacy of transfected siRNA, or that inhibition of Id1
expression slowed cell growth but did not completely block
transformation.
Effects of stably silencing Id1 expression in LMP1 transformed
cells
To ensure that Id1 expression was effectively decreased
throughout the 7- to 10-day transformation assay, the siRNA
Id1 targeting sequence and a control irrelevant sequence were
cloned into a retrovirus. Rat-1 cells were transduced with
control and Id1 siRNA expressing retroviruses and stable cell
lines were selected with puromycin. Cells were then transduced
with HSCG or HSCG-LMP1 retrovirus and cells were tested in
transformation assays for focus formation and colony forma-
tion. In parallel, cells were harvested to confirm knockdown of
Id1. In cells transduced with HSCG or HSCG-LMP1, the cells
expressing the Id1 siRNA had lower Id1 protein expression,
confirming knockdown of Id1 expression (Fig. 7A). The effects
on LMP1 induced transformation in cells stably expressing Id1
siRNA were similar to those observed with the transiently
transfected siRNAwith the formation of fewer and smaller foci
(Fig. 5). The number and size of the crystal violet stained foci
were quantitated using ImageQuant software in five separate
fields for each condition and plotted (Fig. 7B and C,
respectively). The cell lines expressing the Id1 siRNA reduced
the number of the foci by approximately 50% and size of the
foci by about a third in the presence of LMP1. The finding that
foci were produced despite decreased Id1 expression suggests
that in the absence of Id1 LMP1 is still able to transform cells.
However, the decreased number and size of foci suggests that
LMP1 induction of Id1 contributes to cell growth.
To further assess effects on transformation, the cell lines with
decreased Id1 expression were tested for their ability to grow in
an anchorage-independent fashion and form colonies in soft
agar. Equal numbers of siRNA expressing cells were transduced
with control and LMP1 expressing retrovirus overnight and then
an equal number of cells were seeded into soft agar and main-
tained under puromycin selection to maintain siRNA expres-
sion, for ten to 14 days. Cells were examined by phase contrast
and fluorescence microscopy for colony formation. Cells stably
expressing the siRNAs that were transduced with control
retrovirus, HSCG, did not form colonies in soft agar (data not
shown). However, cell lines expressing either nonspecific or Id1
Fig. 5. Transient silencing of Id1 in transformation assays. Rat-1 cells were transfected with negative control (panels A, B, E, F) or Id1 siRNA (panels C, D, G, and H)
in twelve-well plates. The following day cells were transduced with control HSCG retrovirus (panels A, C, E, G), or LMP1-expressing retrovirus, HSCG-LMP1
(panels B, D, F, H) and focus formation assays were performed for 7 days. Monolayers were fixed, stained with crystal violet, and examined for focus formation by
light microscopy using a dissecting microscope. Representative micrographs are depicted at 10X (panels A, B, C, D) or 40X (panels E, F, G, H).
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Fig. 7. Effects of decreased Id1 on focus formation. Rat-1 stable cell lines were analyzed by western blotting for Id1 expression (panel A). Total cell lysates from cell
lines stably expressing control siRNA (Sil-Neg.retro) or Id1 siRNA (Sil-Id1.retro) and transduced with control (HSCG) or LMP1-expressing retrovirus were analyzed
for Id1 levels compared to Actin loading control. Fifty micrograms of protein were loaded per lane. Doubly transduced cells were also seeded in 12-well plates for
focus formation assays for 10 days. Monolayers were fixed and stained with crystal violet and five separate fields were photographed per condition using a dissecting
microscope. The foci were quantitated using ImageQuant software and the mean number and size of foci were plotted (panels B and C, respectively). Error bars
represent the standard deviation in the five separate fields.
Fig. 6. Morphology of LMP1 transformed cells. Rat-1 cells were transfected with negative control (panels A and D) or Id1 siRNA (panels B, C, E, and F) in twelve-
well plates. The following day cells were transduced with LMP1-expressing retrovirus and focus formation assays were performed for 7 days. Monolayers were
examined by phase contrast (panels A–C) and fluorescence microscopy (panels D–F) for focus formation at 10× low power (A, B, D, and E) and 40× high power
(C and F). Representative micrographs are depicted.
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Fig. 8. Effects of reduced Id1 expression in soft agar assays. Equal numbers of Rat-1 stable cell lines expressing control siRNA (Sil-Neg.retro, columns A and B) or Id1
siRNA (Sil-Id1.retro, columns C and D) and transduced with LMP1-expressing retrovirus were seeded into soft agar assays and allowed to grow for 10 to 14 days.
Wells were examined by phase contrast (columns A and C) and fluorescence microscopy (columns B and D) for colony formation at 10× low power. Randomly
selected fields containing one or more colonies are depicted.
Fig. 9. Effects of Id1 silencing on cell growth. Three separate pools of Rat-1
cells were transduced with different retrovirus aliquots expressing control
siRNA (open symbols and dashed lines) or Id1 siRNA (closed symbols and solid
lines) and selected with puromycin for 48 h. Equal numbers of stable cells from
each pool were seeded in duplicate into eight 12-well plates. The next day and
each day afterwards, one plate (containing two wells per pool) was fixed and
stained with DAPI. Four randomly selected fields for each well were
photographed using a fluorescent microscope and DAPI stained nuclei were
counted using the ITCN plugin of ImageJ. The average number of cells per field
for each pool on each day is graphed.
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(Fig. 8 columns A and C, respectively). The cells were fluores-
cent green indicating that they were effectively transduced with
the LMP1 expressing retrovirus (Fig. 8 columns B and D).
Similarly to the focus formation assays, the colonies expressing
Id1 siRNA were smaller compared to cells expressing the neg-
ative control siRNA. These data confirm that Id1 silencing does
not inhibit LMP1-induced transformation to anchorage-inde-
pendence. However, the slower growth of the cells expressing
Id1 siRNA suggests that the Id proteins contribute to enhanced
cell growth.
To assess the effects of silencing Id1 expression on the
growth of Rat-1 cells, equal numbers of three different pools of
separate retrovirus transductions of control and Id1 siRNA
expressing Rat-1 cells were plated in duplicate in eight 12-well
plates and cells were allowed to grow from one to 8 days. Cells
were fixed and stained with DAPI, photographed by fluores-
cence microscopy, and DAPI stained nuclei were counted using
ImageJ using the ITCN plugin. Four different fields were
counted for each duplicate per pool per day and the average
number of cells per field is plotted for each day (Fig. 9). All
three pools expressing the negative control siRNA grew to
confluence by day six or seven at approximately the same rate
(open symbols and dashed lines). Two of Id1 siRNA (closedtriangles and closed diamonds), grew much slower and only
reached about one third of the confluency of the negative pools
by day eight. The third Id1 pool (closed squares) grew to an
266 D.N. Everly Jr. et al. / Virology 376 (2008) 258–269intermediate level, reaching half confluency by about day six
and similar density to the negatives by day eight. These data
indicate that inhibition of Id1 expression in Rat-1 cells impairs
cell growth as the cells grow more slowly and to a lower density
than the control cells.
Discussion
The data presented here assess the contribution of the up-
regulation of the Id proteins by LMP1 to LMP1 transformation
of Rat1 cells. Expression of the Id proteins alone was not
sufficient to transform rodent fibroblast and did not affect the
expression of the cell cycle regulators, p27, cdk2, or Rb.
However, inhibition of Id1 expression impaired the growth of
Rat-1 cells but did not inhibit LMP1-mediated transformation.
These results suggest that LMP1 mediated upregulation of the
Id proteins contributes to enhanced cellular growth independent
of potential effects on the expression of cyclin dependent kinase
inhibitors.
The Id proteins are known regulators of cyclin dependent
kinase inhibitors including p16INK4 and p21WAF1, however,
our data demonstrate that the Id proteins are clearly not
sufficient to downregulate p27KIP expression and that the
distinct cdkis are not regulated in common by the Id proteins.
Distinct mechanisms of regulation of cdkis during cancer
development have also been identified. The loss of expression
of p16 in cancer cells frequently involves genetic mechanisms
including mutation and deletion (Auerkari, 2006). In contrast,
p27 is frequently regulated at the post-transcriptional level
during cancer development and in cancer cells (Viglietto et al.,
2002). These differences in regulation likely reflect the different
properties of the different cdkis.
The data presented here indicate that LMP1 transcriptionally
regulates p27 expression as evidenced by repression of a p27
promoter reporter construct and decreased p27 protein and RNA.
However expression of Id1 or Id3 is not sufficient for this effect.
It is possible that LMP1 affects p27 transcription through
regulation of other pathways independent of the Id proteins or
possibly through the concerted effects of the Id proteins with
other regulators of p27 transcription. One likely target of LMP1
is FOXO3A, which is known to regulate p27 transcription
(Chandramohan et al., 2004). FOXO3A transcriptional activity
is negatively regulated by the kinase Akt. Akt is activated by
LMP1 and the PI3K/Akt pathway is required for LMP1-
mediated transformation (Mainou et al., 2005). Activation of the
PI3K/Akt pathway by LMP1 could phosphorylate and inactivate
FOXO3A leading to the transcriptional downregulation of p27.
It is also possible that LMP1 also post-transcriptionally regulates
p27 expression. The further study of the effects of LMP1 on p27
expression and the functional consequences is likely to reveal
new mechanisms of LMP1-mediated cell control.
The Id proteins have been shown to delay the senescence of
primary cell lines and are frequently highly expressed in a
number of cancers including the EBV-associated tumor,
nasopharyngeal carcinoma (Wang et al., 2002). A recent study
in prostate cancer cells defined distinct properties of the
different Id proteins by specifically inhibiting the expression ofthe Id proteins individually with targeted siRNAs (Asirvatham
et al., 2006). This study indicated that loss of Id1 and Id3
resulted in loss of proliferation, while loss of Id2 did not affect
proliferation but resulted in increased apoptosis. Similarly in
breast cancer cells, inhibition of Id1 expression with siRNA or
antisense RNA resulted in a growth defect similar to inhibition
of myc expression (Swarbrick et al., 2005). In the current study,
inhibition of Id expression similarly affected proliferation of
Rat-1 cells. This inhibition did not block transformation as the
LMP1 transformed cells still had altered morphology, formed
foci under contact-inhibiting conditions, and produced colonies
in an anchorage-independent fashion. However, the impairment
of cell growth suggests that Id1 and Id3 induced by LMP1
contribute to the enhanced growth of LMP1 expressing cells.
Identification of the target genes and pathways affected by Id
induction in LMP1 transformed cells may lead to the iden-
tification of new targets of LMP1 that contribute to enhanced
cellular growth and vitality.
Materials and methods
Plasmids
The cloning of wild type LMP1 into retrovirus packaging
vector pBabe was previously described (Everly et al., 2004).
LMP1was subcloned into a retrovirus-packaging vector, pHSCG
(a kind gift of Lishan Su, University of North Carolina, Chapel
Hill), which co-expresses a gene of interest under control of the
LTR and GFP under the CMV promoter in order to identify
transduced cells by green fluorescence. HA-tagged LMP1 was
amplified by pcr with Platinum Pfx (Invitrogen) according to the
manufacturer's instructions with HA-EcoRI5′ (gccgaattcatggct-
tacccatacgatgttccag) and LMP1-SalI3′ (gcggtccagaatgtggctttt-
cagcctagac), digested with EcoRI and SalI and ligated into
pHSCG digested with EcoRI and XhoI by compatible ends.
Retrovirus expressing Id1 siRNA, pSilencer-Id1, was con-
structed by inserting Id1 specific sequences into pSilencer™ 5.1-
U6 retro (Ambion) according to the manufacturer's directions.
Id1 primers siId13805′ (gatccgtcgcgaccgccggaggccttcaaga-
gaggcctccggcggtcgcgacttttttggaaa) and siId13803′ (agcttttc-
caaaaaagtcgcgaccgccggaggcctctcttgaaggcctccggcggtcgcgacg)
were mixed at 1 mg/ml in 1x annealing solution (Ambion),
boiled, slowly cooled, and ligated into pSilencer™ 5.1-U6 retro
digested with BamHI and HindIII by compatible ends. Mature
siRNA produced in transduced cells should target the sequence
ttgtcgcgaccgccggaggcc from 380 to 400 bp in the Rattus
novegicus Id1 message (GenBank accession NM_012797).
Retroviruses expressing untagged and myc-tagged Id1 and
Id3 were constructed by cloning into pBabe and pM3-Babe,
respectively, described previously (Mainou et al., 2007). Human
Id1 (GenBank accession NM_002165) was subcloned from
pLXSN-Id1 (kindly provided by Pierre-Yves Desprez, Califor-
nia Pacific Medical Research Institute) by pcr amplification
as described above with Id1KZ5′ (cgacggatccctgccaccatgaaag-
tcgccagtggcagc) and EcoId13′ (atcacgaggaattccgcttcagcgaca-
caagatgc) with BamHI and EcoRI. Id3 (GenBank accession
NM_013058) was cloned from cDNA generated from total Rat-
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Reverse Transcriptase (Invitrogen) according to the manufac-
turer's instructions with RNId3E3′ (atcacgaggaattcaggacgaccg-
ggtcagtggc), followed by pcr with RNId3E3′ and Id3KZ5′
(cgacggatccctgccaccatgaaggcgctgagcccggtgcgcggc) and clon-
ing using BamHI and EcoRI. Resulting constructs express
untagged or amino-terminal triple myc-tagged protein Id1 and
Id3 protein. Caborxyl-terminal HA-tagged Id1 and Id3 pBabe
vectors were produced by amplification of Id1 and Id3 by pcr
with the same 5′ primers, Id1KZ5′ and Id3KZ5′, respectively,
with Id1C-HA′ (ggcgaattcctaaccggtacgagcgtaatctggaacatcgtat-
gggtaagctccggtgcgacacaagatgcgatcgtc) and Id3C-HA′ (ggcgaa-
ttcctaaccggtacgagcgtaatctggaacatcgtatgggtaagctccggtgtgg-
caaaaactcctcttgtcc), respectively, as described above.
A promoter reporter construct containing upstream regula-
tory sequence of p27Kip1/cyclin-dependent kinase inhibitor 1B
of Rattus novegicus was constructed. Control sequences for the
p27 promoter were amplified from Rat-1 genomic DNA using
p27RN-5′ (gacagatctgaggaaggaaggagctgttgtagttggcg) and
p27RN-3′ (gacagatctcttcctccccgggcgggtgtgg) as described
above and cloned into the BglII site of pGL3-Basic (Promega).
The resulting promoter reporter plasmid contains sequences
1140 base pairs upstream of the transcription start site and the
360 base pair 5′ untranslated region up to but not including the
translation start site for a total of 1500 base pairs.
The Rat p27Kip1/cyclin-dependent kinase inhibitor 1B gene
was cloned for generation of rat-specific ribonuclease protection
probes. The gene for p27Kip1 (GenBank accession NM_031762)
was amplified from genomic DNA as described above using
p27RN5′ (cgacggatccatatgtcaaacgtgagagtgtctaacggg) and
p27RN3′ (atcacgaggaattcggagctgtttacgtctggcg) and cloned into
the BamHI and EcoRI sites of pcDNA3 (Invitrogen). Digestion
with BamHI followed by in vitro transcription with SP6 RNA
polymerase will yield a probe that will protect exon 1 and exon 2
of the rat p27Kip1 gene in ribonuclease protection assays.
Transfection and retrovirus transduction
Cells were transfected with FuGENE 6 (Boehringer Man-
nheim) according to the manufacturer's directions. Recombinant
retroviruses were generated as previously described (Scholle
et al., 2000) by transfection of 293T cells with pHSCG, pHSCG-
LMP1, pBABE, pBABE-HA-LMP1, pBABE-Id1, pBABE-Id3,
pSilencer-Neg (nonspecific siRNA expression vector, Ambion),
or pSilencer-Id1, and VSV-G (pG1-VSV-G) and gag-pol (pGPZ9)
expressing plasmids. After 24 h, transfection media was removed
and replaced with fresh media, and cells were incubated at 33 °C
overnight. The following day culture supernatants were harvested
and centrifuged 1000×g for 10 min to remove any cells or cellular
debris. Rat-1 cells were transduced with clarified 293T culture
supernatants overnight with 8 μg/ml polybrene.
Cell culture and stable cell lines
Cell lines were maintained in Dulbecco modified Eagle
medium (Gibco) supplemented with antibiotic/antimycotic mix-
ture and 10% (v/v) heat-inactivated fetal bovine serum (FBS).Rat-1, rodent fibroblast, stable cell lines were established by
transduction with retrovirus and selection with puromycin (1 μg/
ml, Sigma). For serum starvation, selected cells were grown to
confluence and then changed to media with 0.2% serum for 24 h.
Id1 silencing
Transient silencing of Id1 was accomplished by transfection
with small interfering RNAs. Transfection was optimized using
siRNATransfectionOptimization Kit fromAmbion according to
the manufacturer's directions using predesigned Cy3-labelled
negative-control and GAPDH silencer siRNA, Ambion. Id1
siRNA as selected from Ambion's predesigned siRNA database
and transfected according to the optimized conditions with
siPORT™ NeoFX™ transfection agent (Ambion). Knockdown
of targets was confirmed by western blotting and ribonuclease
protection assays.
Ribonuclease protection assay
Ribonuceotide protection assays (RPA) were performed using
a Direct Protect™ Lysate RPA kit (Ambion) according to the
manufacturer's directions. Briefly, RPA probes were annealed
with RNA overnight in lysis buffer. The following day samples
were digestedwith RNase and protease and precipitated. Protected
probes were resolved on a 5% polyacrylamide gel, dried, and
imaged using a PhosphorImager (Molecular Dynamics). Bands
were quantitated using ImageQuant 5.1 (Molecular Dynamics)
and p27 expression was determined relative to GAPDH levels.
Cell harvesting and western blotting
Cell lines were grown in 100-mm tissue culture plates to
confluency and harvested. Cells were washed with ice cold
phosphate buffered saline (PBS, Gibco) and lysed with 100–
250 μl RIPA buffer (10 mM Tris–HCl, pH 8.0, 140 mM NaCl,
1% Triton X-100, 0.1% SDS, 1% deoxycholic acid, protease
and phosphatase inhibitors (Sigma)). Cell lysates were clarified
by centrifugation and quantitated by Bio-Rad DC protein assay
system (Bio-Rad). Samples were then boiled in SDS sample
buffer and indicated amounts of proteins were separated using
10 or 15% acrylamide SDS-PAGE, and transferred to Optitran
membranes (Whatman) for western blotting analysis. Primary
antibodies used included β-Actin (I-19), c-myc (9E10), Id1 (C-
20 and Z-8), and Id3 (H-70) (Santa Cruz), p27 (Calbiochem),
Cdk2 (55) and Rb (G3-245) (BD Biosciences), and CS1-4 (anti-
LMP1) (Dako). Bound proteins were detected with horseradish
peroxidase-conjugated secondary antibodies (Amersham Phar-
macia and Dako) and Pierce Supersignal West Pico System
(Pierce) followed by exposure to film. Relative protein
expression was quantitated using ImageJ software, http://rsb.
info.nih.gov/ij/ (Rasband, 1997–2007).
Rat-1 foci and soft agar assays
Rat-1 cells or Rat-1 stable cell lines were plated 1:5 in 6- or
12-well plates and infected the following day with retroviruses
268 D.N. Everly Jr. et al. / Virology 376 (2008) 258–269with 8 μg/ml polybrene. The media was changed the following
day and every 2 to 3 days thereafter, and foci were allowed to
form for 10 to 15 days. Cells were examined by phase contrast
and fluorescence microscopy or transduction and transforma-
tion and stained with 1% crystal violet in 50% ethanol and
imaged with stereo microscopy. The number and size of foci
were quantified using ImageQuant-TL v2005 (GE Healthcare)
using the colony counting functions.
Soft agar assays were performed as described previously
(Scholle et al., 2000). Briefly, Bacto agar medium (5% Bacto
agar diluted in DMEMwith 10% FBS to a final concentration of
0.5%) was poured into 12-well plates and allowed to solidify.
1–2×105 cells were suspended in Bacto agar medium and over-
laid the solidified wells. Once solidified, the cell-agar suspen-
sions were feed every few days for 14–21 days with normal
media containing puromycin to maintain the expression of
the Id1 siRNA. Colonies were imaged with phase contrast and
fluorescence microscopy.
p27 promoter luciferase assays
Cells were plated 1:5 into 12-well plates 1 day prior to
transfection. Cells were transfected with 0.2 μg of pRL-SV40
(Promega), 0.2 μg of pGL3-Basic or p27–1501 promoter
plasmids, and 0.2 μg of pBABE or pBABE-expression clones.
The following day the media was changed, and 40 h post-
transfection cells were harvested and luciferase activity was
assayed using the Dual-Luciferase® Reporter Assay System
(Promega) according to the manufacturer's directions. Relative
luciferase activity was determined by dividing the firefly
luciferase activity of the p27 promoter constructs by the internal
control Renilla luciferase activity. Each condition was done in
triplicate and replicated in different experiments.
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